新規登録 | ログイン | FAQ      [?] 

Medical Oncology

最近発刊の雑誌の目次より: Medical Oncology © Humana Press
  • Tissue levels of adiponectin in breast cancer patients
    Medical Oncology, Vol. 24, No. 4. (December 2007), pp. 361-366.
  • A casecontrol study of non-alcoholic fatty liver disease in breast cancer
    Medical Oncology, Vol. 24, No. 4. (December 2007), pp. 367-371.
  • Combination chemotherapy employing bispecific antisense oligonucleotides having binding sites directed against an autocrine regulated growth pathway and bcl-2 for the treatment of prostate tumors
    Medical Oncology, Vol. 24, No. 4. (December 2007), pp. 372-378.
  • The results of hypofractionated radiotherapy in 31 patients with high-grade gliomas
    Medical Oncology, Vol. 24, No. 4. (December 2007), pp. 379-383.
  • Adjuvant chemoradiation for patients with adenocarcinoma of the pancreas: an expirence of single institute
    Medical Oncology, Vol. 24, No. 4. (December 2007), pp. 384-387.
    by Yazar, , Ustuner, , Sakar, , Kaytan Saglam, , Camlica, , Aykan,
  • Lack of prognostic value of EGFR mutations in primary resected non-small cell lung cancer
    Medical Oncology, Vol. 24, No. 4. (December 2007), pp. 388-393.
  • Inhibition of cell invasion and MMP production by a nutrient mixture in malignant liposarcoma cell line SW-872
    Medical Oncology, Vol. 24, No. 4. (December 2007), pp. 394-401.
  • Phase I study of paclitaxel, carboplatin and UFT in chemo-naive patients with advanced non-small cell lung cancer (NSCLC)
    Medical Oncology, Vol. 24, No. 4. (December 2007), pp. 402-406.
  • Phase II studies on docetaxel alone every third week, or weekly in combination with gemcitabine in patients with primary locally advanced, metastatic, or recurrent esophageal cancer
    Medical Oncology, Vol. 24, No. 4. (December 2007), pp. 407-412.
  • Immunophenotypic profile and clinical characteristics in patients with advanced stage mantle cell lymphoma
    Medical Oncology, Vol. 24, No. 4. (December 2007), pp. 413-418.
  • The cell growth, morphology and immunocytochemistry of novel cell line established from a bone marrow of the patient with therapy-related myelodysplastic syndrome, entitled PC-MDS
    Medical Oncology, Vol. 24, No. 4. (December 2007), pp. 419-424.
  • Prognostic factors for malignant pericardial effusion treated by pericardial drainage in solid-malignancy patients
    Medical Oncology, Vol. 24, No. 4. (December 2007), pp. 425-430.
  • Capecitabine plus oxaliplatin (xelox) in the treatment of chemotherapy-naive patients with metastatic colorectal cancer
    Medical Oncology, Vol. 24, No. 4. (December 2007), pp. 431-435.
  • Position-dependent expression of GADD45 in rat brain tumours
    Medical Oncology, Vol. 24, No. 4. (December 2007), pp. 436-444.
  • Systemic lupus Erythematosus and IgA multiple myeloma: a rare association?
    Medical Oncology, Vol. 24, No. 4. (December 2007), pp. 445-448.
  • Malignant mesothelioma of the tunica vaginalis testis: a case report and review of the literature
    Medical Oncology, Vol. 24, No. 4. (December 2007), pp. 449-452.
  • Tamoxifen induced-thrombocytopenia: it does occur
    Medical Oncology, Vol. 24, No. 4. (December 2007), pp. 453-454.
  • Tumor lysis syndrome after treatment with gemcitabine for metastatic transitional cell carcinoma
    Medical Oncology, Vol. 24, No. 4. (December 2007), pp. 455-457.
  • Lung, bone, skeletal muscles and cutaneous metastases from adenoid cystic carcinoma of the parotid gland: a case report and review of the literature
    Medical Oncology, Vol. 24, No. 4. (December 2007), pp. 458-462.
  • Solitary iris metastasis from breast cancer with dramatic course: case report
    Medical Oncology, Vol. 24, No. 4. (December 2007), pp. 463-465.
  • Metachronous non-Hodgkin's lymphoma in a patient with localized prostate cancer
    Medical Oncology, Vol. 24, No. 4. (December 2007), pp. 466-468.
  • Two cases of sarcoidosis-lymphoma syndrome
    Medical Oncology, Vol. 24, No. 4. (December 2007), pp. 469-471.
  • Immunoglobulin Gene Analysis of Mature B-Cell Malignancies: Reconsideration of Cellular Origin and Potential Antigen Involvement in Pathogenesis
    Medical Oncology, Vol. 22, No. 4. (December 2005), pp. 327-342.
    by Sarah H Walsh, Richard Rosenquist
  • Adjuvant Chemotherapy in 780 Patients with Early Breast Cancer: 10-Year Data from Saudi Arabia
    Medical Oncology, Vol. 22, No. 4. (December 2005), pp. 343-352.
    by Ezzeldin M Ibrahim, Adnan A Ezzat, Mohammed M Rahal, Madras M Raja, Dahish S Ajarim
  • Serum Levels of Leptin and Proinflammatory Cytokines in Advanced-Stage Non-Small Cell Lung Cancer
    Medical Oncology, Vol. 22, No. 4. (December 2005), pp. 353-358.
    by Faruk Tas, Derya Duranyildiz, Andac Argon, Hilal Oguz, Hakan Camlica, Vildan Yasasever, Erkan Topuz
  • Gemcitabine Plus Carboplatin in Patients with Advanced Non-Small Cell Lung Cancer
    Medical Oncology, Vol. 22, No. 4. (December 2005), pp. 359-366.
    by Se H Park, Seong H Jeong, Sun Y Kyung, Young-Hee Lim, Chang H An, Sang P Lee, Jeong W Park, Soo M Bang, Eun K Cho, Dong B Shin, Jae H Lee
  • Induction and Concurrent Chemotherapy with Concomitant Boost Radiotherapy in Non-Small Cell Lung Cancer
    Medical Oncology, Vol. 22, No. 4. (December 2005), pp. 367-374.
    by Ethem N Oral, Adnan Aydiner, Yesim Eralp, Erkan Topuz
  • Role of Gross Tumor Volume on Outcome and of Dose Parameters on Toxicity of Patients Undergoing Chemoradiotherapy for Locally Advanced Non-Small Cell Lung Cancer
    Medical Oncology, Vol. 22, No. 4. (December 2005), pp. 375-382.
    by Luigi De Petris, Ingmar Lax, Florin Sirzen, Signe Friesland
  • Residual Disease After Chemotherapy in Aggressive Malignant Lymphoma: The Role of Radiotherapy
    Medical Oncology, Vol. 22, No. 4. (December 2005), pp. 383-388.
    by Agustin Aviles, Natividad Neri, Serafin Delgado, Felipe Perez, Jesus M Nambo, Sergio Cleto, Alejandra Talavera, Judith Huerta-Guzman
  • Overexpression of Cyclooxygenase-2 in Gastric Cancer Correlates with the High Abundance of Vascular Endothelial Growth Factor-C and Lymphatic Metastasis
    Medical Oncology, Vol. 22, No. 4. (December 2005), pp. 389-398.
    by Jin Liu, Hong-Gang Yu, Jie-Ping Yu, Xiao-Ling Wang, Xiao-Dong Zhou, He-Sheng Luo
  • Implications of Therapy Choice on Overall Survival in Metastatic Renal Cell Carcinoma: A Single Institution Experience
    Medical Oncology, Vol. 22, No. 4. (December 2005), pp. 399-406.
    by Simrit Parmar, Alfred W Rademaker, Bing B Fung, James M Kozlowski, Timothy M Kuzel
  • Spontaneous Remission in Adults with Primary Myelodysplastic Syndromes: Incidence and Characteristics of Patients
    Medical Oncology, Vol. 22, No. 4. (December 2005), pp. 407-410.
    by Dragomir Marisavljevic, Zoran Rolovic, Milena Ludoski-Pantic, Vesna Djordjevic, Angelina Novak
  • Prognostic Usage of VH Gene Mutation Status and Its Surrogate Markers and the Role of Antigen Selection in Chronic Lymphocytic Leukemia
    Medical Oncology, Vol. 22, No. 3. (September 2005), pp. 217-228.
    by Gerard Tobin, Richard Rosenquist
  • The Safety of Full-Dose Chemotherapy with Secondary Prophylactic Granulocyte Colony Stimulating Factor (G-CSF) Following a Prior Cycle with Febrile Neutropenia
    Medical Oncology, Vol. 22, No. 3. (September 2005), pp. 229-232.
    by Nissim Haim, Katerina Shulman, Hadassah Goldberg, Medy Tsalic
  • Tumor Parameters, Clinical and Pathological Responses, Medical Management, and Survival Through Time on 710 Operable Breast Cancers
    Medical Oncology, Vol. 22, No. 3. (September 2005), pp. 233-240.
  • The Value of Serum Levels of IL-6, TNF-alpha, and Erythropoietin in Metastatic Malignant Melanoma: Serum IL-6 Level Is a Valuable Prognostic Factor at Least as Serum LDH in Advanced Melanoma
    Medical Oncology, Vol. 22, No. 3. (September 2005), pp. 241-246.
    by Faruk Tas, Hilal Oguz, Andac Argon, Derya Duranyildiz, Hakan Camlica, Vildan Yasasever, Erkan Topuz
  • Therapeutic Efficacy by Recombinant Human Granulocyte/ Monocyte-Colony Stimulating Factor on Mucositis Occurring in Patients with Oral and Oropharynx Tumors Treated with Curative Radiotherapy: A Multicenter Open Randomized Phase III Study
    Medical Oncology, Vol. 22, No. 3. (September 2005), pp. 247-256.
    by Giuseppe Masucci, Peter Broman, Charles Kelly, Sten Lindahl, Lena Malmberg, Johan Reizenstein, Martin Alenius, Rolf Lewensohn
  • Phase I Trial of Infusional Cyclophosphamide, Doxorubicin, and Etoposide plus Granulocyte-Macrophage Colony Stimulating Factor (GM-CSF) in Non-Hodgkin's Lymphoma
    Medical Oncology, Vol. 22, No. 3. (September 2005), pp. 257-268.
    by Joseph A Sparano, Abdissa Negassa, Erick Lansigan, Robin Locke, Chamath R De Silva, Peter H Wiernik
    posted by 1 person dyaro
  • Paclitaxel, Cisplatin, Leucovorin, and Continuous Infusion Fluorouracil Followed by Concomitant Chemoradiotherapy for Locally Advanced Squamous Cell Carcinoma of the Head and Neck: A Hellenic Cooperative Oncology Group Phase II Study
    Medical Oncology, Vol. 22, No. 3. (September 2005), pp. 269-280.
    by George Fountzilas, Christos Tolis, Anna Kalogera-Fountzila, Despina Misailidou, Periklis Tsekeris, Maria Karina, Angelos Nikolaou, Epaminondas Samantas, Thomas Makatsoris, Eleni Athanassiou, Dimosthenis Skarlos, Aristotelis Bamias, Nikolas Zamboglou, Theofanis Economopoulos, Sophia Karanastassi, Nicholas Pavlidis, John Daniilidis
  • A Phase II Study of Dose-Intensified Weekly Concomitant Administration of Cisplatin and Irinotecan in Chemonaive Patients with Extensive-Disease Small-Cell Lung Cancer
    Medical Oncology, Vol. 22, No. 3. (September 2005), pp. 281-290.
    by Ji-Youn Han, Dae H Lee, Sung Y Lee, Chun G Park, Hae Y Kim, Eun-A Kim, Sung M Yoon, Hong G Lee, Jin S Lee
  • Signaling Molecules and Cytokine Production in T Cells of Patients with B-Cell Chronic Lymphocytic Leukemia (B-CLL): Comparison of Indolent and Progressive Disease
    Medical Oncology, Vol. 22, No. 3. (September 2005), pp. 291-302.
    by Shahryar Kiaii, Aniruddha Choudhury, Fariba Mozaffari, Eva Kimby, Anders Osterborg, Hakan Mellstedt
  • Liver Resection after Irinotecan, 5-Fluorouracil, and Folinic Acid for Patients with Unresectable Colorectal Liver Metastases: A Multicenter Phase II Study by the Cancer Therapeutic Research Group
    Medical Oncology, Vol. 22, No. 3. (September 2005), pp. 303-312.
    by Wing M Ho, B Ma, Tony Mok, W Yeo, Paul Lai, R Lim, Jane Koh, YY Wong, Ann King, CK Leow, Chan
  • Isolated Skeletal Muscle Recurrence of the Paranasal Sinus Lymphoma in Complete Remission
    Medical Oncology, Vol. 22, No. 3. (September 2005), pp. 313-318.
    by Hakan Karagol, Duygu Derin, Mert Basaran, Sevil Bavbek
  • Mantle Cell Lymphoma Presenting with Paraproteinemia
    Medical Oncology, Vol. 22, No. 3. (September 2005), pp. 319-324.
    by Grzegorz Rymkiewicz, Monika Gos, Katarzyna Blachnio, Renata Woroniecka, Pawel Swoboda, Barbara Pienkowska-Grela, Marika Kulinska, Anna Borawska, Przemyslaw Janik, Jan Walewski
  • Molecular Diagnosis of Cancer: Methods and Protocols, Second Edition
    Medical Oncology, Vol. 22, No. 3. (September 2005), pp. 325-326.
    by Janis Racevskis
  • Metastatic Melanoma: Is Biochemotherapy the Future?
    Medical Oncology, Vol. 22, No. 2. (June 2005), pp. 101-112.
    by Doru T Alexandrescu, Janice P Dutcher, Peter H Wiernik
  • Involvement of the Epstein-Barr Virus in the Nasopharyngeal Carcinoma Pathogenesis
    Medical Oncology, Vol. 22, No. 2. (June 2005), pp. 113-122.
    by Javier S Burgos
  • Changes of Cerebrospinal Fluid Tumor Marker Levels May Predict Response to Treatment and Survival of Carcinomatous Meningitis in Patients with Advanced Breast Cancer
    Medical Oncology, Vol. 22, No. 2. (June 2005), pp. 123-128.
    by Christos Kosmas, Nicolas B Tsavaris, Georgia Soukouli, Panagiotis Gouveris, George Tsakonas, John Katselis, Heraklis Alexopoulos, Nicolas Mylonakis, Athanasios Karabelis
  • In Vitro and In Vivo Antitumorigenic Activity of a Mixture of Lysine, Proline, Ascorbic Acid, and Green Tea Extract on Human Breast Cancer Lines MDA-MB-231 and MCF-7
    Medical Oncology, Vol. 22, No. 2. (June 2005), pp. 129-138.
    by Waheed W Roomi, Vadim Ivanov, Tatiana Kalinovsky, Aleksandra Niedzwiecki, Matthias Rath
  • The Value of Serum Bcl-2 Levels in Advanced Lung Cancer Patients
    Medical Oncology, Vol. 22, No. 2. (June 2005), pp. 139-144.
    by Faruk Tas, Derya Duranyildiz, Hilal Oguz, Hakan Camlica, Ethem N Oral, Vildan Yasasever, Erkan Topuz
  • 注: このページを引用する時は次のURLでどうぞ: http://www.citeulike.org/journal/hum-mo

    Result page: 1 2 Next RIS BibTeX
    CiteULike organises scholarly (or academic) papers or literature and provides bibliographic (which means it makes bibliographies) for universities and higher education establishments. It helps undergraduates and postgraduates. People studying for PhDs or in postdoctoral (postdoc) positions. The service is similar in scope to EndNote or RefWorks or any other reference manager like BibTeX, but it is a social bookmarking service for scientists and humanities researchers.